A precursor is a compound that participates in the chemical reaction that produces another compound. In biochemistry, the term
"precursor" is used more specifically to refer to a chemical compound
preceding another in a metabolic pathway. The first
ever bio precursor was made for Malaria.
Plasmodium falciparum is
responsible of the most severe form of malaria, and new targets and novel
chemotherapeutic scaffolds are needed to fight emerging multidrug-resistant
strains of this parasite. Bis-alkylguanidines have been designed to mimic
choline, resulting in the inhibition of plasmodial biosynthesis.
Despite potent
in vitro antiplasmodial and in vivo antimalarial activities, a major downside
of these compounds for advance clinical growth is their short oral
bioavailability. To explain this issue, several modulations were performed on
bis-alkylguanidines. The introduction of N-disubstituents on the guanidine
motif amended both in vitro and in vivo activities. On the other hand, in vivo
pharmacological assessment in a mouse model showed that the N-hydroxylated
derivatives constitute the first oral bioprecursors in bis-alkylguanidine
sequences.
The article Design
and Applications of Bioprecursors: A Retrometabolic Approach has given
detailed information about bio precursor and their link for it to be a
Retrometabolic approach. Also, the journal Current
Drug Metabolism focuses on the roots of pharmacokinetics and
pharmacodynamics.
No comments:
Post a Comment